2,5-Dihydroxybiphenyl
CAS No. 1079-21-6
2,5-Dihydroxybiphenyl( 2-Phenylhydroquinone | TFIIH Modulator-12 )
Catalog No. M27365 CAS No. 1079-21-6
TFIIH Modulator-12, a small molecule destabilization inducer, induces the dimerization of trichothiodystrophy group A protein to modulate TFIIH transcriptional activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 63 | In Stock |
|
| 25MG | 103 | In Stock |
|
| 50MG | 150 | In Stock |
|
| 100MG | 223 | In Stock |
|
| 500MG | 482 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2,5-Dihydroxybiphenyl
-
NoteResearch use only, not for human use.
-
Brief DescriptionTFIIH Modulator-12, a small molecule destabilization inducer, induces the dimerization of trichothiodystrophy group A protein to modulate TFIIH transcriptional activity.
-
DescriptionTFIIH Modulator-12, a small molecule destabilization inducer, induces the dimerization of trichothiodystrophy group A protein to modulate TFIIH transcriptional activity.
-
In Vitro——
-
In Vivo——
-
Synonyms2-Phenylhydroquinone | TFIIH Modulator-12
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1079-21-6
-
Formula Weight186.21
-
Molecular FormulaC12H10O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOc1ccc(O)c(c1)-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Heni Rachmawati, et al. The In Vitro-In Vivo Safety Confirmation of PEG-40 Hydrogenated Castor Oil as a Surfactant for Oral Nanoemulsion Formulation. Sci Pharm. 2017 Mar 31;85(2):18. doi: 10.3390/scipharm85020018.
molnova catalog
related products
-
Ornipressin Acetate(...
Ornipressin Acetate is a potent vasoconstrictor, hemostatic and renal agent.
-
SJ000291942
SJ000291942 is an activator of the canonical bone morphogenetic proteins (BMP) signaling pathway.
-
Urocortin II, human
Human urocortin (hUcn) II is a new member of the corticotropin-releasing-factor (CRF) family. It selectively binds to the CRF2 receptor.
Cart
sales@molnova.com